Table 1 Profiles of HIV-infected... | American Society of Hematology

Table 1

Profiles of HIV-infected subjects

Subject	Plasma viral load, copies per mL*	CD4 T cells, per μL	CD8 T cells, per μL	ART at the time of study†	Duration of therapy, year
ART subjects
1	<50	235	399	3TC, D4T, NVP	7
2	<50	490	369	FTC, RAL, TDF	3
3	<50	1116	737	3TC, ABC, EFV	6
4	<50	434	583	3TC, ABC, EFV	3
5	<50	396	645	3TC, ABC, AZT	4
6	<50	375	515	EFV, FTC, TDF	7
7	<50	1065	1468	EFV, FTC, TDF	8
8	<50	1177	935		7
9	<50	367	652	3TC, ABC, LPV/RTV	5
10	<50	558	972	3TC, ABC, LPV/RTV	9
11	<50	794	608	3TC, AZT, EFV	7
12	<50	422	1269	3TC, ABC, LPV/RTV, TDF	4
13	<50	959	822	3TC, ABC, ATV	6
14	<50	1183	912	3TC, ABC, ATV	3
15	<50	436	1125	3TC, ABC, LPV/RTV, TDF	12
16	<50	1220	1206	FTC, LPV/RTV, TDF	6
17	<50	890	673	3TC, AZT, NVP	4
18	<50	291	491	3TC, ABC, ATV/RTV	3
Untreated subjects
1	17 000	321	450	No	NA
2	24 000	415	821	No	NA
3	25 138	364	544	No	NA
4	32 594	368	491	No	NA
5	95 543	566	1330	No	NA
6	268 417	880	1250	No	NA
7	19 041	657	544	No	NA

Subject	Plasma viral load, copies per mL*	CD4 T cells, per μL	CD8 T cells, per μL	ART at the time of study†	Duration of therapy, year
ART subjects
1	<50	235	399	3TC, D4T, NVP	7
2	<50	490	369	FTC, RAL, TDF	3
3	<50	1116	737	3TC, ABC, EFV	6
4	<50	434	583	3TC, ABC, EFV	3
5	<50	396	645	3TC, ABC, AZT	4
6	<50	375	515	EFV, FTC, TDF	7
7	<50	1065	1468	EFV, FTC, TDF	8
8	<50	1177	935		7
9	<50	367	652	3TC, ABC, LPV/RTV	5
10	<50	558	972	3TC, ABC, LPV/RTV	9
11	<50	794	608	3TC, AZT, EFV	7
12	<50	422	1269	3TC, ABC, LPV/RTV, TDF	4
13	<50	959	822	3TC, ABC, ATV	6
14	<50	1183	912	3TC, ABC, ATV	3
15	<50	436	1125	3TC, ABC, LPV/RTV, TDF	12
16	<50	1220	1206	FTC, LPV/RTV, TDF	6
17	<50	890	673	3TC, AZT, NVP	4
18	<50	291	491	3TC, ABC, ATV/RTV	3
Untreated subjects
1	17 000	321	450	No	NA
2	24 000	415	821	No	NA
3	25 138	364	544	No	NA
4	32 594	368	491	No	NA
5	95 543	566	1330	No	NA
6	268 417	880	1250	No	NA
7	19 041	657	544	No	NA

NA, not applicable.

Viral load was measured by the Amplicor HIV-1 monitor ultrasensitive method (Roche), with a detection limit of 50 copies per milliliter of plasma.

†

Antiretroviral therapy: 3TC, lamivudine; ABC, abacavir; ATV, atazanavir; AZT, zidovudine; d4T, stavudine; EFV, efavirenz; FTC, Emtricitabine; LPV, lopinavir; NPV, nevirapine; RAL, raltegravir; RTV, ritonavir; TDF, tenofovir.

View Large

This Feature Is Available To Subscribers Only